QDEL

QuidelOrtho Corporation

Quidel Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration has issued the first emergency use authorization for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic.

QuidelOrtho Corporation (QDEL) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B (3.3) C+ (2.7) B (3.2) C+ (2.8) C+ (2.6) B- (2.9)
2026-11-07 B (3.3) C+ (2.7) B (3.2) C+ (2.6) C+ (2.7) B- (2.9)
2026-10-31 B (3.3) C+ (2.8) B (3.2) D+ (1.8) C+ (2.7) C+ (2.8)
2026-10-24 B (3.3) C+ (2.8) B (3.2) C- (1.9) C+ (2.6) C+ (2.8)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe